TTLC 2022

Why attend TTLC 2022?

Exceptional Education

Presentations will summarize information about ongoing clinical trials of the newest therapies for lung cancer including data on preclinical and early clinical data.

Connect & Collaborate

Build connections with colleagues from around the world including prominent researchers and physicians.

Present & Discuss

Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies.

Advertising, Promotion & Exhibits

Market to one of the most unique gatherings of researchers, clinicians and professionals in the field of lung cancer and thoracic oncology.

Important Dates:

November 1, 2021Abstract Submission Opens
December 1, 2021Registration Opens
December 3, 2021
(23:59 PST)
Abstract Submission Deadline
December 20, 2021Abstract Notifications of Acceptance/Rejection
February 9, 2022
(23:59 PST)
Presenting Author Registration Deadline
February 11, 2022Full Abstract Release
February 22 – 26, 2022Meeting

TTLC 2022 Will Be Going Hybrid!

The longstanding highly interactive virtual meeting will feature novel research on emerging combination immunotherapy approaches and targets. Join us to meet professionals from around the world from the comfort of your own home.